Development of a BiTE^®-mediated CD8⁺ cytotoxic T-lymphocyte activity assay to assess immunomodulatory potential of drug candidates in Cynomolgus macaque

References

• Abraham M, Karni A, Dembinsky A, Miller A, Gandhi R, Anderson D, Weiner L. 2008. In vitro induction of regulatory T-cells by anti-CD3 antibody in humans. J Autoimmun. 30:21–28.
   PubMed Web of Science ®Google Scholar
• Aktas E, Kucuksezer U, Bilgic S, Erten G, Deniz G. 2009. Relationship between CD107a expression and cytotoxic activity. Cell Immunol. 254:149–154.
   PubMed Web of Science ®Google Scholar
• Axelsson S, Faresjo M, Hedman M, Ludvigsson J, Casas R. 2008. Cryopreserved peripheral blood mononuclear cells are suitable for the assessment of immunological markers in Type 1 diabetic children. Cryobiology. 57:201–208.
   PubMed Web of Science ®Google Scholar
• Betts M, Brenchley J, Price D, de Rosa S, Douek D, Roederer M, Koup R. 2003. Sensitive and viable identification of antigen-specific CD8+ T-cells by a flow cytometric assay for degranulation. J Immunol Methods. 281:65–78.
   PubMed Web of Science ®Google Scholar
• Betts M, Koup R. 2004. Detection of T-cell degranulation: CD107a and b. Methods Cell Biol. 75:497–512.
   PubMed Web of Science ®Google Scholar
• Brennan F, Morton L, Spindeldreher S, Kiessling A, Allenspach R, Hey A, Muller P, Frings W, Sims J. 2010. Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies. mAbs. 2:233–255.
   PubMed Web of Science ®Google Scholar
• Bull M, Lee D, Stucky J, Chiu Y, Rubin A, Horton H, McElrath M. 2007. Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials. J Immunol Methods. 322:57–69.
   PubMed Web of Science ®Google Scholar
• Burkett M, Shafer-Weaver K, Strobl S, Baseler M, Malyguine A. 2005. A novel flow cytometric assay for evaluating cell-mediated cytotoxicity. J Immunother. 28:396–402.
   PubMed Web of Science ®Google Scholar
• Ceuppens J, Baroja M, Lorre K, van Damme J, Billiau A. 1988. Human T-cell activation with phytohemagglutinin. The function of IL-6 as an accessory signal. J Immunol. 141:3868–3874.
   PubMed Web of Science ®Google Scholar
• Choi B, Gedeon P, Herndon J, Archer G, Reap E, Sanchez-Perez L, Mitchell D, Bigner D, Sampson J. 2013. Human regulatory T-cells kill tumor cells through granzyme-dependent cytotoxicity upon retargeting with a bispecific antibody. Cancer Immunol Res. 1:163–167.
   PubMed Web of Science ®Google Scholar
• Frauwirth K, Thompson C. 2002. Activation and inhibition of lymphocytes by costimulation. J Clin Invest. 109:295–299.
   PubMed Web of Science ®Google Scholar
• Furue M, Ishibashi Y. 1991. Differential regulation by dexamethasone and cyclosporine of human T-cells activated by various stimuli . Transplantation. 52:522–526.
   PubMed Web of Science ®Google Scholar
• Gutsol AA, Sokhonevich NA, Yurova KA, Khaziakhmatova OG, Shupletsova VV, Litvinova LS. 2015. Dose-dependent effects of dexamethasone on functional activity of T-lymphocytes at different grade of differentiation. Molek Biol. 49:130–157.
   Web of Science ®Google Scholar
• ICH. 2005. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Immunotoxicity Studies for Human Pharmaceuticals S8. (Recommended for Adoption at Step 4 of ICH Process, 9/15/2005).
   Google Scholar
• Jana S, Campbell H, Woodliff J, Waukau J, Jailwala P, Ghorai J, Ghosh S, Glisic S. 2010. The type of responder T-cell has a significant impact in a human in vitro suppression assay. PloS One. 5:e15154.
   PubMed Web of Science ®Google Scholar
• Jeurink P, Vissers Y, Rappard B, Savelkoul H. 2008. T-cell responses in fresh and cryopreserved peripheral blood mononuclear cells: Kinetics of cell viability, cellular subsets, proliferation, and cytokine production. Cryobiology. 57:91–103.
   PubMed Web of Science ®Google Scholar
• Kamperschroer C, O’Donnell LM, Schneider PA, Li D, Roy M, Coskran TM, Kawabata TT. 2014. Measuring T-cell responses against LCV and CMV in Cynomolgus macaques using ELISPOT: Potential application to non-clinical testing of immunomodulatory therapeutics. J Immunotoxicol. 11:35–43.
   PubMed Web of Science ®Google Scholar
• Kay J. 1991. Mechanisms of T-lymphocyte activation. Immunol Lett. 29:51–54.
   PubMed Web of Science ®Google Scholar
• Klenerman P, Oxenius A. 2016. T-cell responses to cytomegalovirus. Nat Rev Immunol. 16:367–377.
   PubMed Web of Science ®Google Scholar
• Lamers C, van de Griend R, Braakman E, Ronteltap C, Benard J, Stoter G, Gratama J, Bolhuis R. 1992. Optimization of culture conditions for activation and large-scale expansion of human T-lymphocytes for bispecific antibody-directed cellular immunotherapy. Int J Cancer. 51:973–979.
   PubMed Web of Science ®Google Scholar
• Laszlo GS, Gudgeon CJ, Harrington KH, Walter RB. 2015. T-cell ligands modulate the cytolytic activity of the CD33/CD3 BiTE antibody construct, AMG 330. Blood Cancer J. 5:e340.
   PubMed Web of Science ®Google Scholar
• Lebrec H, Brennan F, Haggerty H, Herzyk D, Kamperschroer C, Maier C, Ponce R, Preston B, Weinstock D, Mellon R. 2016. HESI/FDA workshop on immunomodulators and cancer risk assessment: Building blocks for a weight-of-evidence approach. Regul Toxicol Pharmacol. 75:72–80.
   PubMed Web of Science ®Google Scholar
• Levine BL, Mosca JD, Riley JL, Carroll RG, Vahey MT, Jagodzinski LL, Wagner KF, Mayers DL, Burke DS, Weislow OS, et al. 1996. Antiviral effect and ex vivo CD4+ T-cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science. 272:1939–1943.
   PubMed Web of Science ®Google Scholar
• Lutterbuese R, Raum T, Kischel R, Hoffmann P, Mangold S, Rattel B, Friedrich M, Thomas O, Lorenczewski G, Rau D, et al. 2010. T-cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells. Proc Natl Acad Sci USA. 107:12605–12610.
   PubMed Web of Science ®Google Scholar
• Mallone R, Mannering S, Brooks-Worrell B, Durinovic-Bello I, Cilio C, Wong F, Schloot N, T-Cell Workshop Committee IoDS. 2011. Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T-cell responses: Position statement of T-Cell Workshop Committee of the Immunology of Diabetes Society. Clin Exp Immunol. 163:33–49.
   PubMed Web of Science ®Google Scholar
• Mazur P. 1984. Freezing of living cells: Mechanisms and implications. Am J Physiol. 247:C125–C142.
   PubMed Web of Science ®Google Scholar
• McLeod J, Walker L, Patel Y, Boulougouris G, Sansom D. 1998. Activation of human T-cells with superantigen (Staphylococcal enterotoxin B) and CD28 confers resistance to apoptosis via CD95. J Immunol. 160:2072–2079.
   PubMed Web of Science ®Google Scholar
• O’Connor SL, Blasky AJ, Pendley CJ, Becker EA, Wiseman RW, Karl JA, Hughes AL, O’Connor DH. 2007. Comprehensive characterization of MHC Class II haplotypes in Mauritian Cynomolgus macaques. Immunogenetics. 59:449–462.
   PubMed Web of Science ®Google Scholar
• Ross S, Sherman M, McElroy P, Lofgren J, Moody G, Baeuerle P, Coxon A, Arvedson T. 2017. Bi-specific T-cell engager (BiTE®) antibody constructs can mediate bystander tumor cell killing. PloS One. 12:e0183390.
   PubMed Web of Science ®Google Scholar
• Rubio V, Stuge T, Singh N, Betts M, Weber J, Roederer M, Lee P. 2003. Ex vivo identification, isolation and analysis of tumor-cytolytic T-cells. Nat Med. 9:1377.
   PubMed Web of Science ®Google Scholar
• Shi Y, Wu W, Wan T, Liu Y, Peng G, Chen Z, Zhu H. 2013. Impact of polyclonal anti-CD3/CD28-coated magnetic bead expansion methods on T-cell proliferation, differentiation and function. Int Immunopharmacol. 15:129–137.
   PubMed Web of Science ®Google Scholar
• Smith EJ, Olson K, Haber LJ, Varghese B, Duramad P, Tustian AD, Oyejide A, Kirshner JR, Canova L, Menon J, et al. 2016. A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and Cynomolgus molgus monkeys. Sci Reports. 5:17943.
   Web of Science ®Google Scholar
• Teschner D, Wenzel G, Distler E, Schnurer E, Theobald M, Neurauter A, Schjetne K, Herr W. 2011. In vitro stimulation and expansion of human tumour-reactive CD8+ cytotoxic T-lymphocytes by anti-CD3/CD28/CD137 magnetic beads. Scand J Immunol. 74:155–164.
   PubMed Web of Science ®Google Scholar
• Tran D. 2013. In vitro suppression assay for functional assessment of human regulatory T-cells. In: Snow A, Lenardo M, editors. Immune homeostasis: Methods and protocols. Totowa, NJ: Humana Press; p. 199–212.
   Google Scholar
• Trickett A, Kwan Y. 2003. T-cell stimulation and expansion using anti-CD3/CD28 beads. J Immunol Methods. 275:251–255.
   PubMed Web of Science ®Google Scholar
• Turner S, Cross R, Xie W, Doherty P. 2001. Concurrent naive and memory CD8+ T-cell responses to an influenza A virus. J Immunol. 167:2753–2758.
   PubMed Web of Science ®Google Scholar
• Walsh C, Zydowsky L, McKeon F. 1992. Cyclosporin A, the cyclophilin class of peptidylprolyl isomerases, and blockade of T-cell signal transduction. J Biol Chem. 267:13115–13118.
   PubMed Web of Science ®Google Scholar